BMC Infect Dis. 2013;13:332.
Pseudomonas aeruginosa bacteremia in patients with liver cirrhosis: a comparison with bacteremia caused by Enterobacteriaceae.
제1저자 방지환, 정영희 · 교신저자 김남중
소속 (1)
- Department of Internal Medicine, Seoul National University College of Medicine, 101 Daehak-ro Jongno-gu, 110-744, Seoul, Republic of Korea.
Abstract
BACKGROUND This study was performed to detect risk factors for Pseudomonas aeruginosa bacteremia in patients with liver cirrhosis.
METHODS A retrospective case-control study was designed to identify risk factors for P. aeruginosa bacteremia in cirrhotic patients. The cases were cirrhotic patients with P. aeruginosa bacteremia and the controls were cirrhotic patients with Enterobacteriaceae bacteremia.
RESULTS Sixty-one cases and the same number of controls were enrolled. In a multivariate analysis, younger age {adjusted odds ratio (aOR) per one year: 0.96, 95% confidence interval: 0.93 - 0.99}, nosocomial acquisition (aOR 3.87, 95% confidence interval: 1.50 - 9.94), preexisting biliary disease (aOR 4.79, 95% confidence interval: 1.92 - 10.47), and recent exposure to immunosuppressive agent (aOR 3.10, 95% confidence interval: 1.23 - 7.82) were associated with P. aeruginosa bacteremia. In the case group the frequency of appropriate initial antibiotic regimens was considerably lower than in the control group: 29.5% vs. 65.6% (P <0.01). However, thirty day mortality did not differ significantly between cases and controls (19.7% vs. 24.6%).
CONCLUSIONS Nosocomial acquisition, preexisting biliary disease, and recent use of immunosuppressive agents are strong predictive factors for P. aeruginosa bacteremia in cirrhotic patients.
그 밖의 정보
- 출판 형태
- Journal Article
- 저널
- BMC infectious diseases · eISSN 1471-2334
- 전자 출판
- 2013-07-19
- MeSH
- Adult · Aged · Anti-Bacterial Agents / therapeutic use · Bacteremia / complications / drug therapy / microbiology · Case-Control Studies · Enterobacteriaceae / isolation & purification · Enterobacteriaceae Infections / complications / drug therapy / microbiology · Female · Humans · Liver Cirrhosis / drug therapy / microbiology · Male · Middle Aged · Multivariate Analysis · Odds Ratio · Pseudomonas Infections / complications / drug therapy / microbiology · Pseudomonas aeruginosa · Risk Factors · Treatment Outcome
- Substances
- Anti-Bacterial Agents
- 참고문헌
- 26편